Intravenous Lidocaine Offers Alternative for ICU Patients' Pain

Share this content:
Intravenous Lidocaine Offers Alternative for ICU Patients' Pain
Intravenous Lidocaine Offers Alternative for ICU Patients' Pain

THURSDAY, Feb. 9, 2017 (HealthDay News) -- Intravenous lidocaine (IVLI) seems safe for reducing pain among patients in the intensive care unit (ICU) with varying degrees of organ dysfunction, according to research published online Feb. 7 in the Journal of Clinical Pharmacology.

Yoonsun Mo, Pharm.D., from Long Island University in Brooklyn, N.Y., and colleagues conducted a retrospective chart review to examine the safety and effectiveness of IVLI for the treatment of pain in ICU patients with varying degrees of organ dysfunction. Data were included for 21 ICU patients from two hospitals.

The researchers found that the mean time to a ≥20 percent reduction in pain scores was 3.3 hours from the start of IVLI. The median morphine dose equivalents were significantly higher during six, 12, and 24 hours pre-IVLI compared with the same time periods after IVLI (18.3 versus 10 mg [P = 0.002], 41.8 versus 18.3 mg [P = 0.002], and 93.5 versus 30.5 mg [P = 0.037], respectively). Three patients experienced neurological adverse effects of lidocaine, but these were reversed on discontinuation of IVLI.

"This report suggests that IVLI as an adjunctive agent in the treatment of acute pain may be a potential option in ICU patients who are refractory to opioids or those in whom opioid-induced respiratory depression is a concern," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »